FDAnews Drug Daily Bulletin

GSK Completes Trials for Combination Lung Drug

Aug. 27, 2012
A A
GlaxoSmithKline has completed final stage testing of its experimental once-daily lung disease drug LAMA/LABA and will press ahead with plans to file for approval of the medicine in global markets from the end of 2012.
Reuters